Biotechnology remains a key driver of Germany’s economy, contributing significantly to the country’s health and life sciences sector. According to the Global Competition Review, this sector, which includes biotechnology, accounts for 12 percent of economic output and employs about 16 percent of the country’s workforce.
Additionally, Germany continues to draw investment in research centers and innovation, exemplified by Merck’s £1.5 billion investment program in Darmstadt.
Below is a list of companies driving growth in the industry.
Top Biotech Companies in Germany
- Schrödinger, Inc.
- Eucalyptus
- 908 Devices
- Ottobock
- Boehringer Ingelheim
- Regeneron
- Immatics
- Bio-Rad
- EMBL
- Evotec
Biotech Companies in Germany
908 Devices develops handheld portable devices that can quickly and accurately identify chemical substances in any form and regardless of visibility. Founded in Boston, Massachusetts, in 2012, the company has additional offices across the United States and in select locations in Germany.
Regeneron invents and commercializes medicines for serious diseases, using its VelocImmune technology to quickly discover and develop fully human monoclonal antibodies. Its well-known products include Dupixent, EYLEA and Libtayo. The company has offices around the world.
Eucalyptus manages various clinics, such as Pilot for men’s health, Kin for fertility, Software for dermatology, and Juniper for weight loss and menopause. Since its launch in 2019, the company has conducted over a million consultations in several countries, including Germany.
Immatics aims to fight cancer by identifying precise immunotherapy targets and developing T-cell receptors that trigger a strong, specific T-cell response against them. The company’s headquarters are located in Tuebingen, with additional offices in Germany and the United States.
Schrödinger, Inc. offers molecular simulations and software solutions for the pharmaceutical, biotechnology and materials industries. Additionally, the company is developing experimental medicines, with three candidates in clinical trials as of 2025. The first results from these trials are expected in the same year.
Headquartered in Duderstadt, Ottobock aims to advance prosthetics and orthotics by combining human expertise with technology. In 1997, it launched the C-Leg, the world’s first leg prosthesis controlled entirely by microprocessors. The company operates over 240 patient care centers worldwide.
Boehringer Ingelheim is a family-owned multinational corporation focused on human pharmaceuticals, animal health and biopharmaceutical manufacturing. The company states that 15 of the world’s top 20 pharmaceutical companies rely on its biopharmaceutical contract manufacturing services, and, since its founding, it has brought more than 35 biologics to market.
Hamburg-based Evotec accelerates drug discovery and development through partnerships with pharmaceutical companies, biotech firms, foundations and government agencies. By harnessing data and AI to enhance human ingenuity, the company says it aims to deliver the best possible patient care.
Founded over 50 years ago, EMBL is a European life sciences laboratory home to more than 80 independent research groups focused on molecular biology. In addition to research, the organization provides training for scientists, students and visitors at all levels and develops new scientific instruments.
Bio-Rad manufactures and sells antibodies, instruments, software, consumables and reagents for applications in cell biology, gene expression, protein purification, food safety and science education, among others. According to Bio-Rad, it is one of the top five life science companies worldwide.
